Advances in ORMDL Research in Malignant Tumors: A Review
Hao Wang1, Zhongquan Yi2, Song Yan3
1Department of Cardiothoracic Surgery, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng, 224000, People's Republic of China.
Oncotargets and Therapy
|August 4, 2025
Summary
ORMDL proteins regulate sphingolipid metabolism and endoplasmic reticulum homeostasis. Their altered expression in cancer suggests potential as diagnostic biomarkers and therapeutic targets for improved tumor treatment.
Area of Science:
- Cellular Biology
- Oncology
- Biochemistry
Background:
- ORMDL proteins (ORMDL1-3) are endoplasmic reticulum (ER) transmembrane proteins regulating sphingolipid metabolism and cellular stress responses.
- Altered ORMDL expression is observed in various cancers, impacting cell proliferation, apoptosis, and metabolic balance.
- ORMDLs' role in negatively regulating serine palmitoyltransferase (SPT) affects ceramide metabolism crucial for tumor progression.
Purpose of the Study:
- To investigate the role of ORMDL proteins in cancer development and progression.
- To explore ORMDL proteins as potential biomarkers for cancer diagnosis, prognosis, and therapeutic response.
- To evaluate targeting ORMDL proteins or associated metabolic networks as a cancer therapy strategy.
Main Methods:
- Analysis of ORMDL protein expression in various tumor types.
- Investigation of ORMDL-mediated regulation of sphingolipid metabolism and ER homeostasis.
- Assessment of the impact of ORMDL dysregulation on cancer cell behavior and therapeutic resistance.
Main Results:
- Dysregulated ORMDL expression disrupts sphingolipid metabolism, potentially triggering ER stress and impairing autophagy.
- ORMDL protein alterations are linked to tumor cell proliferation, invasiveness, and therapy resistance.
- ORMDL functions influence key pathways in tumor development and progression.
Conclusions:
- ORMDL proteins are implicated in cancer pathogenesis and may serve as valuable biomarkers.
- Targeting ORMDL proteins or their metabolic pathways presents a promising avenue for novel cancer therapies.
- Further research into ORMDLs' roles in the tumor microenvironment and immune interactions is warranted for personalized medicine.
Related Concept Videos
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K